Signant Health Debuts Standardized Electronic Seizure Diary Developed in Collaboration with The Epilepsy Study Consortium
PHILADELPHIA, Jan. 17, 2023 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, introduced today a novel electronic diary (eDiary) data capture solution designed to simplify the experience for patients and research sites participating in epilepsy trials while ensuring robust outcome assessment data to support trial endpoints. Developed in collaboration with The Epilepsy Study Consortium (TESC), the new patient-reported outcome measure offers clinical research sponsors and organizations a standardized solution to capture common seizure-data elements with high-quality data.
- Developed in collaboration with The Epilepsy Study Consortium (TESC), the new patient-reported outcome measure offers clinical research sponsors and organizations a standardized solution to capture common seizure-data elements with high-quality data.
- Epilepsy-related protocols often require study teams to collect data about patients' daily and episodic seizure events, typically captured using paper-based or non-standardized electronic diaries.
- The new electronic seizure diary solution, consisting of two pre-designed, configurable eDiaries, enables sponsors to harness the benefits of electronic data collection and standardize their measurement approach to the assessment of seizure events.
- The electronic seizure diary, available now, can be deployed on the company's flagship Signant SmartSignals eCOA platform.